NEW YORK — The U.S. generics industry, which filled more than 90% of prescriptions and delivered $445 billion in savings in 2023, is facing critical challenges that could shape its future, from supply chain strains to pressures on financial sustainability.
The recording is now available of 'Generics at a Crossroads,' a one-hour webcast featuring senior leaders from Ascend Laboratories, one of the top 10 suppliers in the generics market. Originally held on July 8, 2025, the discussion examined the current state of the generics business, the obstacles to bringing new products to market, and the changes needed to ensure the industry’s long-term health.
Click here to watch the webinar
Panelists included John Dillaway, Executive Vice President of Ascend Laboratories, and Amit Ghare of Ascend Laboratories, with Jeff Woldt, Editor-in-Chief of retailmediaIQ, serving as moderator. The session also explored what sets Ascend apart in a competitive generics landscape.
The webinar offers valuable insights into the business and policy dynamics that shape the future of generic medications and their crucial role in ensuring patient access to affordable treatments.
Watch the recording here to stay informed about the forces driving change in this critical segment of the healthcare sector.
